文献速递关节外科

确定HbA1c作为全关节置换术后不良结局预测指标的阈值:一项多中心回顾性研究

Determining the Threshold for HbA1c as a Predictor for Adverse Outcomes After Total Joint Arthroplasty: A Multicenter, Retrospective Study.
PubMed 文献 · J Arthroplasty · 2017-05-11

该多中心回顾性研究纳入2001至2015年间接受初次全关节置换术的1645例糖尿病患者,评估HbA1c与术后1年假体周围感染(PJI)的关联。结果显示HbA1c阈值7.7可区分PJI风险(AUC 0.65,95%CI 0.51-0.78),高于此阈值者PJI发生率从0.8%升至5.4%,HbA1c升高与PJI风险增加独立相关(OR 1.5,95%CI 1.2-2.0,P=.0001),而与其他并发症无关联。

要点

  • HbA1c阈值7.7%对预测PJI具有区分度,AUC为0.65(95%CI 0.51-0.78)。
  • HbA1c≥7.7%者PJI发生率为5.4%(11/204),低于此阈值者为0.8%(11/1441)。
  • HbA1c升高与PJI风险增加独立相关(OR 1.5,95%CI 1.2-2.0,P=.0001),与其他并发症无关联。

核心结论

  • 高HbA1c水平与PJI风险增加相关。
  • HbA1c阈值7.7%似乎比常用的7%更能指示感染风险,或许应作为术前患者优化的目标。

研究设计与样本

  • 多中心回顾性研究,纳入2001至2015年间接受初次全关节置换术的1645例糖尿病患者(1004膝和641髋)。
  • 所有患者均在手术前3个月内测量HbA1c。
  • 主要结局为术后1年基于肌肉骨骼感染学会(MSIS)标准的PJI。

主要发现

  • 术后1年共发生22例PJI(1.3%)。
  • HbA1c阈值7.7%对预测PJI具有区分度(AUC 0.65,95%CI 0.51-0.78)。
  • 使用该阈值,PJI发生率从0.8%(11/1441)升至5.4%(11/204)。
  • 逐步logistic回归分析中,PJI是唯一与较高HbA1c相关的变量(OR 1.5,95%CI 1.2-2.0,P=.0001)。
  • 高HbA1c水平与评估的其他并发症无关联。

关键数值与推荐

  • PJI诊断基于肌肉骨骼感染学会(MSIS)标准。
  • HbA1c阈值7.7%的AUC为0.65(95%CI 0.51-0.78)。
  • HbA1c≥7.7%组PJI发生率为5.4%(11/204),<7.7%组为0.8%(11/1441)。
  • HbA1c与PJI的OR为1.5(95%CI 1.2-2.0,P=.0001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although HbA1c is commonly used for assessing glycemic control before surgery, there is no consensus regarding its role and the appropriate threshold in predicting adverse outcomes. This study was designed to evaluate the potential link between HbA1c and subsequent periprosthetic joint infection (PJI), with the intention of determining the optimal threshold for HbA1c. METHODS: This is a multicenter retrospective study, which identified 1645 diabetic patients who underwent primary total joint arthroplasty (1004 knees and 641 hips) between 2001 and 2015. All patients had an HbA1c measured within 3 months of surgery. The primary outcome of interest was a PJI at 1 year based on the Musculoskeletal Infection Society criteria. Secondary outcomes included orthopedic (wound and mechanical complications) and nonorthopedic complications (sepsis, thromboembolism, genitourinary, and cardiovascular complications). A regression analysis was performed to determine the independent influence of HbA1c for predicting PJI. RESULTS: Overall 22 cases of PJI occurred at 1 year (1.3%). HbA1c at a threshold of 7.7 was distinct for predicting PJI (area under the curve, 0.65; 95% confidence interval, 0.51-0.78). Using this threshold, PJI rates increased from 0.8% (11 of 1441) to 5.4% (11 of 204). In the stepwise logistic regression analysis, PJI remained the only variable associated with higher HbA1c (odds ratio, 1.5; confidence interval, 1.2-2.0; P = .0001). There was no association between high HbA1c levels and other complications assessed. CONCLUSION: High HbA1c levels are associated with an increased risk for PJI. A threshold of 7.7% seems to be more indicative of infection than the commonly used 7% and should perhaps be the goal in preoperative patient optimization.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Tarabichi M, Shohat N, Kheir MM, et al. Determining the Threshold for HbA1c as a Predictor for Adverse Outcomes After Total Joint Arthroplasty: A Multicenter, Retrospective Study. J Arthroplasty. 2017. PMID: 28662955. doi:10.1016/j.arth.2017.04.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。